RISFAX August 18, 2017
日本語- s.maX: Wholesaler MS detail, products approved in July rank in top positions
- Mitsubishi Tanabe commences a Phase II/III trial of antibody medicine for osteoarthritis in Japan
- POLA Pharma licenses out its radiosensitizer to US Shuttle Pharmaceuticals
- Shizuoka-based Suzuki Yakuhin starts rehabilitation proceedings, the business to be continued by a new company
- ◆Note◆ Change in community-based healthcare and sales of pharma companies, think about future of MR